Skip to main content
SpringerLink
Log in

Non-blood Product Agents for Bleeding Disorders

  • Chapter
  • First Online:
Hemostasis and Thrombosis

  • 2613 Accesses

Abstract

This chapter discussed the use of desmopressin, tranexamic acid, epsilon-aminocaproic acids, estrogens, and rVIIa. Several non-plasma-derived agents exist for therapy of bleeding disorders. All of these agents share the common qualities of being relatively nonspecific and having potential life-threatening complications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Suggested Reading

  • Franchini M, Lippi G. Recombinant activated factor VII: mechanisms of action and current indications. Semin Thromb Hemost. 2010;36(5):485–92.

    Article  CAS  PubMed  Google Scholar 

  • Franchini M. The use of desmopressin as a hemostatic agent: a concise review. Am J Hematol. 2007;82(8):731–5.

    Article  CAS  PubMed  Google Scholar 

  • Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054. doi:10.1136/bmj.e3054.

    Article  PubMed Central  PubMed  Google Scholar 

  • Napolitano LM, Cohen MJ, Cotton BA, Schreiber MA, Moore EE. Tranexamic acid in trauma: how should we use it? J Trauma Acute Care Surg. 2013;74(6):1575–86.

    Article  PubMed  Google Scholar 

  • Schulman S. Pharmacologic tools to reduce bleeding in surgery. Hematology Am Soc Hematol Educ Program. 2012;2012:517–21.

    PubMed  Google Scholar 

  • Yank V, Tuohy CV, Logan AC, Bravata DM, Staudenmayer K, Eisenhut R, Sundaram V, McMahon D, Olkin I, McDonald KM, Owens DK. Stafford RS systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications. Ann Intern Med. 2011;154(8):529–40.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pathology and Pediatrics, Oregon Health and Science University, Portland, OR, 97239, USA

    Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M. (Professor of Medicine)

Authors
  1. Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas G. DeLoughery M.D., F.A.C.P., F.A.W.M. .

Editor information

Editors and Affiliations

  1. Medicine, Pathology, and Pediatrics, Oregon Health & Science University, Portland, Oregon, USA

    Thomas G. DeLoughery

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

DeLoughery, T.G. (2015). Non-blood Product Agents for Bleeding Disorders. In: DeLoughery, T. (eds) Hemostasis and Thrombosis. Springer, Cham. https://doi.org/10.1007/978-3-319-09312-3_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-09312-3_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-09311-6

  • Online ISBN: 978-3-319-09312-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation